Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.

导出原文传递

翻译打印收藏纠错

第一作者： Pu,Zhang

第一单位： Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China.

作者： Pu,Zhang ^[1] ; Mengxin,Xu ^[1] ; Jie,Ding ^[2] ; Junyi,Chen ^[1] ; Taiping,Zhang ^[3] ; Li,Huo ^[4] ; Zhibo,Liu ^[5]

作者单位： Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China. ^[1] Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China. ^[2] Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China. ^[3] Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China. huoli@pumch.cn. ^[4] Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, 100871, Beijing, China. zbliu@pku.edu.cn. ^[5] Peking University-Tsinghua University Center for Life Sciences, Beijing, 100871, China. zbliu@pku.edu.cn. ^[6]

关键词 Albumin binder FAPI Radionuclide therapy